Services
- Preclinical
- Early Phase
Who We Serve
START Locations
About
- Company
- Leadership
- Principal Investigators
- Careers
- Resources
  - Blog
  - Events
  - Newsroom
  - Patient Stories
  - Press
  - Publications
  - Webinars
- Contact
Patients & Family
Referring Physicians
Find a Trial

Services
- Preclinical
- Early Phase
Who We Serve
START Locations
About
- Company
- Leadership
- Principal Investigators
- Careers
- Resources
  - Blog
  - Events
  - Newsroom
  - Patient Stories
  - Press
  - Publications
  - Webinars
- Contact
Patients & Family
Referring Physicians
Find a Trial

Press

Targeted Therapies for Cancer, Insights from Dr. María de Miguel

Leave a Comment / Press / Lauren Panco

Targeted Therapies for Cancer, Insights from Dr. María de Miguel Read More »

EMBARK: Real-World Practical Tips for Using Enzalutamide for High-Risk Biochemical Recurrence

Leave a Comment / Press / Lauren Panco

EMBARK: Real-World Practical Tips for Using Enzalutamide for High-Risk Biochemical Recurrence Read More »

Improving Access to Phase 1 Cell & Gene Therapy Trials in Europe: Perspectives from Dr. Victor Moreno

Leave a Comment / Press / Lauren Panco

Improving Access to Phase 1 Cell & Gene Therapy Trials in Europe: Perspectives from Dr. Victor Moreno Read More »

Dr. Maria de Miguel Analyzes the Future of ADCs in Oncology

Leave a Comment / Press / Lauren Panco

Dr. Maria de Miguel Analyzes the Future of ADCs in Oncology Read More »

Clinical Trials in Community Settings: How Do We Improve Participation?

Leave a Comment / Press / Lauren Panco

Clinical Trials in Community Settings: How Do We Improve Participation? Read More »

START Dublin – the need, the science, and the pure serendipity of it all

Leave a Comment / Press / Lauren Panco

START Dublin – the need, the science, and the pure serendipity of it all Read More »

Dr. Victor Moreno on the Pharmacodynamics of CLN-619 in Advanced Solid Tumors

Leave a Comment / Press / Lauren Panco

Dr. Victor Moreno on the Pharmacodynamics of CLN-619 in Advanced Solid Tumors Read More »

After Wife Dies from Non-Smoking Lung Cancer, Utah Man Urges All to Test for Radon

Advocating for Patient Access with Amita Patnaik, MD, FRCPC

Circle Pharma Announces First Patients Dosed in Phase 1 Clinical Trial of First-in-Class Oral Cyclin A/B RxL Inhibitor CID-078 for Advanced Solid Tumors

Partnership

Quis volutpat scelerisque quis massa in dolor nunc lectus cursus.

Varius nec, elit turpis amet, proin ut sed nec donec auctor dolor arcu, sollicitudin.

Enim nulla elementum sodales dapibus orci, sed quam mattis aliquam dui penatibus aliquet feugiat nisl laoreet placerat pellentesque duis semper pellentesque tempor placerat nam parturient magna volutpat auctor mattis imperdiet sapien ut tortor id amet tempor tortor, augue facilisi mi.

Who We Serve

Patients
Pharma
Hospitals & Oncology Practices

Services

Preclinical
Early Phase

About

Company
Leadership
Principal Investigators
Careers
Contact

Resources

Blog
Events
Newsroom
Patient Stories
Press
Publications
Webinars

START Locations

START - San Antonio
START - Midwest
START - Mountain Region
START - Carolinas
START - Madrid - CIOCC
START - Madrid - FJD
START - Barcelona
START - Rioja
START - Lisbon
START - Dublin

Patients & Family

Explore Clinical Trials
About Clinical Trials
Patient Stories

Referring Physicians

Find a Trial

Facebook Linkedin X-twitter

Privacy Policy
Cookie Policy
Site Map